California psychoactive compound activists are embarking on a bold journey, filing a petition for the 2022 ballot to make the state the first in the nation to legalize psilocybin mushrooms for any use.
Exploring the companies and themes that make up this emerging and exciting new sector
Post-COVID Investment Mega-Opportunity: Mental Health and Psychedelic Drug Stocks
As COVID-19 recedes, a much larger pandemic has been exposed -- the Mental Health Pandemic. A huge crisis; an enormous opportunity.
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
Psytech Inc is becoming a wholly-owned subsidiary of Wesana Health for an acquisition price of CAD$21 million in an all-share transaction.
Are Joe Biden And Congress Patriotic Enough To Legalize Psychedelic Medicine?
"Support the troops" the White House and Congress tell Americans, over and over. When will THEY start to support the troops? Psychedelic medicine would be a great place to start.
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD
Numinus receives Health Canada approval to move forward with MAPS in its clinical testing for PTSD.
DMT, active component in ayahuasca, aids in the growth of new neurons
In addition to being found naturally in animal tissues, including the human brain, N,N-dimethyltryptamine is the primary hallucinogenic compound found in the psychedelic brew known as ayahuasca.
How Should We Do Drugs Now?
After a half century spent waging war on drugs, Americans seem ready to sue for peace.
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio
Cybin seeks to build an international footprint via scaling up activities in Europe with its Ireland subsidiary, including the transfer of its IP assets.
Let’s Defund The DEA
The U.S. Drug Enforcement Agency is a bureaucratic relic that regularly demonstrates it has no place in a world of 21st century drug reform.
Rhode Island Governor Signs Historic Bill Legalizing Safe Consumption Sites For Illicit Drugs
The governor of Rhode Island on Wednesday signed a bill to establish a safe consumption site pilot program where people could test and use currently illicit drugs in a medically supervised environment. It’s the first state in the country to legalize the harm reduction centers.
Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial
Novamind's clinics have been selected as a research site by atai-partner, Bionomics Limited for a Phase IIb clinical trial.
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company
MindMed's new partnership with Datavant will enhance its data-collection/data-reporting as MindMed moves through its clinical trials.